Scarica l'app Stockscreener
4.50
3.45%
0.15
Dopo l'orario di chiusura:
4.48
-0.02
-0.44%
Precedente Chiudi:
$4.35
Aprire:
$4.4
Volume 24 ore:
161.49K
Relative Volume:
1.91
Capitalizzazione di mercato:
$25.77M
Reddito:
$257.00K
Utile/perdita netta:
$-3.07M
Rapporto P/E:
-4.7234
EPS:
-0.9527
Flusso di cassa netto:
$-1.40M
1 W Prestazione:
-4.26%
1M Prestazione:
-7.22%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$4.1118
$4.5999
Intervallo di 1 settimana:
$4.1118
$4.99
Portata 52W:
$4.00
$6.20
Optimi Health Corp Stock (OPTH) Company Profile
Compare OPTH vs TAK, TEVA, HLN, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OPTH
Optimi Health Corp
|
4.50 | 24.91M | 257.00K | -3.07M | -1.40M | -0.9527 |
TAK
Takeda Pharmaceutical Co Adr
|
18.11 | 58.15B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.35 | 42.94B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.22 | 40.59B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
72.86 | 30.29B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
503.86 | 21.74B | 3.17B | 1.29B | 1.01B | 27.09 |
Optimi Health Corp Borsa (OPTH) Ultime notizie
Optimi Health plans phase 2 psilocybin trial for depression By Investing.com - Investing.com South Africa
OPTH Stock Price, Quote & News - Syfe
OPTH Looks 64.2% Overvalued on GF Value™ - GuruFocus
Optimi Health Launches Health Canada-Authorized Phase 2 Psilocybin Trial for Major Depressive Disorder - kalkine.ca
Optimi Health To Initiate Phase 2 Psilocybin Trial For Major Depression - RTTNews
Optimi Health Announces Health Canada-Authorized Phase 2 Trial of Natural Psilocybin for Major Depressive Disorder - Quiver Quantitative
A 200-person psilocybin depression trial is coming from Optimi Health (OPTH); here’s when and where - Stock Titan
Optimi Health to Initiate Phase 2 Clinical Trial Evaluating Psilocybin-Assisted Therapy for Major Depressive Disorder - Yahoo Finance
Optimi Health Stock Under Pressure: Can Psychedelic Growth Overcome Rising Execution and Funding Risks? - kalkine.ca
symbol__ Stock Quote Price and Forecast - CNN
Optimi Health to Present at H.C. Wainwright Global Investment Conference - TipRanks
Optimi Health to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Investing News Network
Optimi Health Corp. to Present at H.C. Wainwright 28th Annual Global Investment Conference in September 2026 - kalkine.ca
SRx Health Decided To Invest In A Psychedelic Drug Company That Just Went Public – Here’s What Aided The Decision - Stocktwits
Psychedelic-drug maker Optimi Health (OPTH) plans investor meetings in New York - Stock Titan
Optimi Health Corp. Common Shares (NASDAQ: OPTH) Stock Price, News & Analysis - Kalkine
Optimi Health Stock Faces Renewed Pressure as Psychedelic-Sector Sentiment Weakens - kalkine.ca
Optimi Health (CN:OPTI) Drops 4.12% as Revenue Weakness, Funding Risk and Psychedelic-Sector Uncertainty Pressure Sentiment - kalkine.ca
Optimi Health (OPTH) lines up discounted share funding with new $100M facility - Stock Titan
Optimi Health Corp. SEC Filing (Aug 26, 2026) - Stock Titan
Optimi Health Sets Up US$100 Million Equity Line for Psychedelic Drug Expansion - TipRanks
3 Revenue Generating Psychedelics Stocks Retail Investors Are Screening Right Now - Yahoo Finance
Top Optimi Health (OPTH) Competitors 2026 - MarketBeat
Optimi Health Establishes $100 Million Equity Facility as Psychedelic Commercialisation Advances - Yahoo Finance
Optimi Health (OPTH) clears way for resale of shares over 3x its float - Stock Titan
Optimi Health (OPTH) Stock Chart and Price History 2026 - MarketBeat
Optimi Health (OPTH) secures US$100M equity line with convertible note sweeteners - Stock Titan
Optimi Health Corp. Establishes US$100 Million Discretionary Equity Line of Credit with Seven Knots - kalkine.ca
Optimi Health (OPTH) raises $20.7M, posts larger loss and builds cash buffer - Stock Titan
Optimi Health Corp. Announces Up to US$100 Million Equity Line of Credit with Seven Knots - Quiver Quantitative
Optimi Health Establishes Discretionary Equity Facility - Yahoo Finance
Optimi Health Corp. Secures $100 Million Equity Line of Credit with Seven Knots for Psychedelic Pharma Expansion - Kalkine Media
Norton Rose Fulbright advises Optimi Health on equity facility - nortonrosefulbright.com
Optimi Health Corp. announced that it expects to receive $101.5 million in funding from Seven Knots, LLC - marketscreener.com
Optimi Health Stock Slides 3.4% on August 11 — Is This Psychedelics Manufacturer Getting Interesting Again? - kalkine.ca
Optimi Health Corp (CN:OPTI) Shares Under Pressure as Psychedelic Market Uncertainty and Development Risks Weigh on Sentiment - kalkine.ca
Optimi Health Corp. (OPTH) investor reports 8.25% beneficial stake via Cathay Visions - Stock Titan
Optimi Health CEO Dane Stevens holds 456,347 shares after indirect purchase at CDN$ 6.7 - Bitget
Optimi Health (OPTH) CEO adds 3,800 shares at CDN$6.70 - Stock Titan
Optimi Health Corp. Revenue Breakdown – CSE:OPTI - TradingView
Optimi Health Corp. (OPTH) - Zacks Investment Research
Optimi Health Corp. (OPTH) Cash From Operations (Quarterly) - Zacks Investment Research
Optimi Health (OPTH) seeks approval for equity plan and new preferred shares - Stock Titan
Optimi Health Corp. Revenue Breakdown – BOATS:OPTH - TradingView
Optimi Health (CN:OPTI) Advances: Is the Psychedelics Trade Quietly Reawakening? - kalkine.ca
Optimi Health Corp. Revenue Breakdown – NASDAQ:OPTH - TradingView
Optimi Health to Enter Asian Market with PsiloThai Collaboration on Psilocybin Research - TMX Newsfile
OPTH|Optimi Health Ord Shs|Price:4.680|Chg%:-0.070 - TradingKey
Optimi Health (OPTH) CEO boosts stake with 18,700-share buy - Stock Titan
Optimi Health (OPTH) 10K Form and Latest SEC Filings 2026 - MarketBeat
Red Light Holland Announces Corporate Rebrand to Rhelion Life Sciences Corp - Yahoo! Finance Canada
Optimi Health Corp Azioni (OPTH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.56%
1.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):